comprehensive -WSS

comprehensive

author：knowledge 2025-09-27 21:18:10 - browse：349

The Blue Shield of California headquarters building is seen in San Francisco – health care policy from STAT — Eric Risberg/AP

Two dominant Blue Cross Blue Shield companies in California intentionally underreported premiums of certain health plans so they could avoid paying Affordable Care Act taxes, according to new federal whistleblower complaints.

These claims renew concerns about whether health insurance companies have skirted the tax code and to what extent tax fraud could exist in the industry.

Blue Shield of California evaded $111 million in taxes between 2016 and 2020, according to a complaint that was filed with the Internal Revenue Service on June 27. Elevance Health, the parent company of Anthem Blue Cross in California, evaded $60 million in taxes during the same time period, according to a separate complaint filed with the IRS.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： FDA seeks to regulate lab

focus

hotspot

WSS

How the Dana

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Researchers use wearables data and AI to predict preterm birth risk

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Headspace, Meta partner to launch VR meditation app for Quest

A deep dive into Applied Therapeutics’ data, and questions on Cassava

hotspot

comprehensive

leisure time

In Memoriam: Notable people who died in 2023

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Hollywood unions extend contract negotiations for actors

Biogen shutters digital health group, ends Apple study, in cost cutting move

Virginia high school admissions case could be legal follow

STAT Virtual Event: How to Increase Diversity in Clinical Trials

What does generative AI mean for health care? We asked experts

FDA seeks to regulate lab

Duchenne breakthrough therapy leaves behind pioneering families

In his State of the Union, Biden takes clear aim at 'Big Pharma'

focus

Paxlovid should be available without a positive Covid test

WHO recommends dropping component of many flu vaccines

Amylyx ALS drug fails large clinical trial

After a drawn out lobbying fight, ARPA

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Data show record exodus of life scientists from academia

focus

hotspot

knowledge

Wikipedia